These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 16876204)

  • 1. Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.
    Rutkowski JM; Moya M; Johannes J; Goldman J; Swartz MA
    Microvasc Res; 2006 Nov; 72(3):161-71. PubMed ID: 16876204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent Lymphatic Vessel Hyperplasia with Progressive Dysfunction and Distinct Immune Cell Infiltration in Lymphedema.
    Gousopoulos E; Proulx ST; Scholl J; Uecker M; Detmar M
    Am J Pathol; 2016 Aug; 186(8):2193-2203. PubMed ID: 27315777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Important Role of VEGF-C in Promoting Lymphedema Development.
    Gousopoulos E; Proulx ST; Bachmann SB; Dieterich LC; Scholl J; Karaman S; Bianchi R; Detmar M
    J Invest Dermatol; 2017 Sep; 137(9):1995-2004. PubMed ID: 28526302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interstitial protein because of impaired lymph drainage does not induce fibrosis and inflammation in lymphedema.
    Markhus CE; Karlsen TV; Wagner M; Svendsen ØS; Tenstad O; Alitalo K; Wiig H
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):266-74. PubMed ID: 23288156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of inflammation and fibrosis by macrophages in lymphedema.
    Ghanta S; Cuzzone DA; Torrisi JS; Albano NJ; Joseph WJ; Savetsky IL; Gardenier JC; Chang D; Zampell JC; Mehrara BJ
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1065-77. PubMed ID: 25724493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.
    Zampell JC; Elhadad S; Avraham T; Weitman E; Aschen S; Yan A; Mehrara BJ
    Am J Physiol Cell Physiol; 2012 Feb; 302(4):C709-19. PubMed ID: 22049214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.
    Baluk P; Tammela T; Ator E; Lyubynska N; Achen MG; Hicklin DJ; Jeltsch M; Petrova TV; Pytowski B; Stacker SA; Ylä-Herttuala S; Jackson DG; Alitalo K; McDonald DM
    J Clin Invest; 2005 Feb; 115(2):247-57. PubMed ID: 15668734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema.
    Rutkowski JM; Markhus CE; Gyenge CC; Alitalo K; Wiig H; Swartz MA
    Am J Pathol; 2010 Mar; 176(3):1122-9. PubMed ID: 20110415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair.
    Clavin NW; Avraham T; Fernandez J; Daluvoy SV; Soares MA; Chaudhry A; Mehrara BJ
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2113-27. PubMed ID: 18849330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization.
    Jin DP; An A; Liu J; Nakamura K; Rockson SG
    Lymphat Res Biol; 2009; 7(1):47-57. PubMed ID: 19302023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis Facilitates Initial Lymph Formation and Enhances the Dendritic Cell Mobilizing Chemokine CCL21 Without Affecting Migration.
    Karlsen TV; Reikvam T; Tofteberg A; Nikpey E; Skogstrand T; Wagner M; Tenstad O; Wiig H
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2128-2135. PubMed ID: 28935759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Endothelial Growth Factor C (VEGF-C) Sensitizes Lymphatic Endothelial Cells to Oxidative-Stress-Induced Apoptosis through DNA Damage and Mitochondrial Dysfunction: Implications for Lymphedema.
    Hossain L; Gomes KP; Yang X; Liu E; Du Toit J; von der Weid PY; Gibson SB
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.
    Ji RC; Miura M; Qu P; Kato S
    Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis is a key inhibitor of lymphatic regeneration.
    Avraham T; Clavin NW; Daluvoy SV; Fernandez J; Soares MA; Cordeiro AP; Mehrara BJ
    Plast Reconstr Surg; 2009 Aug; 124(2):438-450. PubMed ID: 19644258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Calcitonin Gene-Related Peptide Deficiency Exacerbates Postoperative Lymphedema by Suppressing Lymphatic Capillary Formation and M2 Macrophage Accumulation.
    Matsui S; Tanaka M; Kamiyoshi A; Sakurai T; Ichikawa-Shindo Y; Kawate H; Dai K; Cui N; Wei Y; Tanaka M; Kakihara S; Nakamura K; Yamauchi A; Ishida K; Tanaka S; Kawamata M; Shindo T
    Am J Pathol; 2019 Dec; 189(12):2487-2502. PubMed ID: 31541644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Murine Tail Lymphedema Model.
    Hassanein AH; Sinha M; Neumann CR; Mohan G; Khan I; Sen CK
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33645579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
    Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
    J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
    Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
    Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.